US firm Kalytera Therapeutics, Inc. said it has completed the acquisition of Talent Biotechs Ltd, a privately held Israeli company that develops cannabis-based therapies for medical needs, for over $10 million.
Talent is currently studying the use of cannabidiol (CBD) – an antioxidant...